Page last updated: 2024-09-04

moxifloxacin and pf 04971729

moxifloxacin has been researched along with pf 04971729 in 1 studies

Compound Research Comparison

Studies
(moxifloxacin)
Trials
(moxifloxacin)
Recent Studies (post-2010)
(moxifloxacin)
Studies
(pf 04971729)
Trials
(pf 04971729)
Recent Studies (post-2010) (pf 04971729)
3,1575521,690933992

Protein Interaction Comparison

ProteinTaxonomymoxifloxacin (IC50)pf 04971729 (IC50)
Sodium/glucose cotransporter 1Homo sapiens (human)1.4373
Sodium/glucose cotransporter 2Homo sapiens (human)0.0014
Sodium/glucose cotransporter 2Rattus norvegicus (Norway rat)0.0012
Solute carrier family 5 member 4Homo sapiens (human)0.0009

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cutler, DL; Hickman, A; Huyghe, I; Matschke, K; Sahasrabudhe, V; Saur, D; Shi, H; Terra, SG1

Trials

1 trial(s) available for moxifloxacin and pf 04971729

ArticleYear
A Phase 1, Randomized, Placebo- and Active-Controlled Crossover Study to Determine the Effect of Single-Dose Ertugliflozin on QTc Interval in Healthy Volunteers.
    Clinical pharmacology in drug development, 2018, Volume: 7, Issue:5

    Topics: Adult; Bridged Bicyclo Compounds, Heterocyclic; Cross-Over Studies; Electrocardiography; Female; Healthy Volunteers; Heart Rate; Humans; Male; Middle Aged; Moxifloxacin; Sample Size; Sodium-Glucose Transporter 2 Inhibitors; Young Adult

2018